| EMED Mining Public Limited: Rio Tinto Copper Project Update | |
| | |
|
NICOSIA, CYPRUS--(Marketwired - Nov 5, 2014) - EMED Mining Public Limited (TSX: EMD) (AIM: EMED)
EMED Mining Public Limited
("EMED" or the "Company")
Rio Tinto Copper Project Restart and Permitting Update
EMED Mining Public Limited, the Europe-based minerals development and exploration company, confirms that even though the Junta de Andalucía ("Junta") has granted a three month regulatory extension to approve the Mining Permit for the Rio Tinto Copper Project, the Company confirms that it still expects to receive the final permitting before the end of the year. The three month extension period is self-imposed by the Junta to allow for additional time to complete the complex administrative process related to the final permits and as confirmed by the Junta in its release does not affect the latest schedule for the project.
Following approval of the Final Restoration Plan and the Mining Permit the Company will be fully permitted to enable full scale mining and processing operations.
All activities at the site are advancing at normal pace with the goal of starting wet plant commissioning during the third quarter of 2015.
Enquiries
EMED Mining |
Isaac Querub/ Alberto Lavandeira |
+34 959 59 28 50 |
Canaccord Genuity |
Neil Elliot/Mark Palmer |
+44 207 523 8000 |
Walbrook PR |
Nick Rome |
+44 207 933 8783 |
For further information on the Company's activities, visit www.emed-mining.com.
http://www.rns.com
|
|
|
EMED Mining Public Ltd
|
|
DEVELOPMENT STAGE |
CODE : EMED.L |
ISIN : CY0000100319 |
|
| |
ProfileMarket IndicatorsVALUE : Projects & res.Press releasesAnnual reportRISK : Asset profileContact Cpy |
EMED is a gold and copper development stage company based in Cyprus. EMED develops gold, copper and zinc in Cyprus and in Spain, and holds various exploration projects in Cyprus. Its main assets in development are PROYECTO RIO TINTO in Spain and KLIROU in Cyprus and its main exploration properties are DETVA, STIAVNICA-HODRUSA and BIELY VRCH in Slovakia and KLIROU in Cyprus. EMED is listed in United Kingdom. Its market capitalisation is GBX 54.7 billions as of today (US$ 65.5 billions, € 57.4 billions). Its stock quote reached its lowest recent point on September 18, 2015 at GBX 0.12, and its highest recent level on January 17, 2022 at GBX 404.00. EMED has 135 475 650 shares outstanding. |